Showing results (1-10 of 621) with videos related to
Sort By:
Pageof 63
Diabetes Care|February 20, 2021
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?Andrea Giaccari, Anna Solini, Simona Frontoni, et al.Diabetes & Metabolism|October 22, 2021
MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose toleranceCristina Bianchi, Francesco Raggi, Chiara Rossi, et al.Diabetologia|August 4, 2023
Incretins and cardiovascular disease: to the heart of type 2 diabetes?Anna Solini, Domenico Tricò, Stefano Del PratoDiabetes, Obesity & Metabolism|November 8, 2021
Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitorsGian Paolo Fadini, Stefano Del Prato, Angelo Avogaro, et al.The Lancet Regional Health. Europe|February 8, 2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal riskGian Paolo Fadini, Enrico Longato, Mario Luca Morieri, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 17, 2023
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist CareMario Luca Morieri, Riccardo Candido, Simona Frontoni, et al.American Journal of Hypertension|July 11, 2009
Soluble CD40 ligand levels in essential hypertensive men: evidence of a possible role of insulin resistanceGiuseppe Penno, Laura Pucci, Giulia Dell'Omo, et al.Diabetes, Obesity & Metabolism|September 2, 2005
Unlocking the opportunity of tight glycaemic control. Far from goalStefano Del PratoNature Reviews. Endocrinology|April 9, 2009
Genes, diabetes and cardiovascular risk predictionStefano Del PratoPageof 63